Document is current

Any future updates will be listed below

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy

Crossref DOI link: https://doi.org/10.1186/s13023-015-0311-0

Published Online: 2015-08-22

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark